BICYCLE THERAPEUTICS APPOINTS STEPHEN J. HOFFMAN, M.D., PH.D., AS BOARD CHAIRMAN

CAMBRIDGE, MASS. and CAMBRIDGE, U.K. – July 18, 2016 – Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptides (Bicycles®) platform, announced today the appointment of Stephen J. Hoffman, M.D., Ph.D., as Chairman of the Board of Directors. Read More